igf-1-genetics

Follistatin Gene Therapy Trial

Source http://musculardystrophynews.com/2015/04/16/milo-treats-first-dmd-patients-with-novel-follistatin-gene-therapy/   Clinical stage startup company Milo Biotechnology has begun treating the first Duchenne muscular dystrophy (DMD) patients with follistatin gene therapy. The treatment is being provided through intramuscular injections and its effects in Continue reading